Abstract
Hyperglycaemia that develops during pregnancy and resolves after birth has been recognized for over 50 years, but uniform worldwide consensus is lacking about threshold hyperglycaemic levels that merit a diagnosis of ‘gestational diabetes mellitus’ (GDM) and thus treatment during pregnancy. GDM is currently the most common medical complication of pregnancy, and prevalence of undiagnosed hyperglycaemia and even overt diabetes in young women is increasing. Maternal overweight and obesity, later age at childbearing, previous history of GDM, family history of type 2 diabetes mellitus and ethnicity are major GDM risk factors. Diagnosis is usually performed using an oral glucose tolerance test (OGTT), although a non-fasting, glucose challenge test (GCT) is used in some parts of the world to screen women for those requiring a full OGTT. Dietary modification and increased physical activity are the primary treatments for GDM, but pharmacotherapy, usually insulin, is used when normoglycaemia is not achieved. Oral hypoglycaemic agents, principally metformin and glibenclamide (glyburide), are also used in some countries. Treatment improves immediate pregnancy outcomes, reducing excess fetal growth and adiposity and pregnancy-related hypertensive disorders. GDM increases the risk of long-term complications, including obesity, impaired glucose metabolism and cardiovascular disease, in both the mother and infant. Optimal management of mother and infant during long-term follow-up remains challenging, with very limited implementation of preventive strategies in most parts of the world.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 1 digital issues and online access to articles
$119.00 per year
only $119.00 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carrington, E. R., Shuman, C. R. & Reardon, H. S. Evaluation of the prediabetic state during pregnancy. Obstet. Gynecol. 9, 664–669 (1957).
O’Sullivan, J. B. Gestational diabetes. Unsuspected, asymptomatic diabetes in pregnancy. N. Engl. J. Med. 264, 1082–1085 (1961).
O’Sullivan, J. B. & Mahan, C. M. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13, 278–285 (1964).
Hadden, D. R. Prediabetes and the big baby. Diabet Med. 25, 1–10 (2008).
Metzger, B. E. & Coustan, D. R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21 (Suppl. 2), B161–B167 (1998).
Menke, A., Casagrande, S. & Cowie, C. C. Contributions of A1c, fasting plasma glucose, and 2-hour plasma glucose to prediabetes prevalence: NHANES 2011–2014. Ann. Epidemiol. 28, 681–685 (2018).
Metzger, B. E. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010).
World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy (WHO Press, Geneva, 2013). This paper provides the rationale for, and current basis of, diagnostic recommendations for GDM on a global scale.
Omori, Y. & Jovanovic, L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care 28, 2592–2593 (2005).
Clausen, T. D. et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J. Clin. Endocrinol. Metab. 94, 2464–2470 (2009).
Clausen, T. D. et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31, 340–346 (2008).
Daly, B. et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study. PLOS Med. 15, e1002488 (2018).
Zhu, Y. & Zhang, C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr. Diab. Rep. 16, 7 (2016). This article provides a global review of the relationship between GDM and the risk of later maternal T2DM.
Harville, E. W., Viikari, J. S. & Raitakari, O. T. Preconception cardiovascular risk factors and pregnancy outcome. Epidemiology 22, 724–730 (2011).
Hedderson, M. M., Darbinian, J. A., Quesenberry, C. P. & Ferrara, A. Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus. Am. J. Obstet. Gynecol. 205, 55.e1–55.e7 (2011).
Solomon, C. G. et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278, 1078–1083 (1997).
Retnakaran, R. et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care 38, 844–851 (2015).
Rauh-Hain, J. A. et al. Risk for developing gestational diabetes in women with twin pregnancies. J. Matern. Fetal Neonatal Med. 22, 293–299 (2009).
Morikawa, M. et al. Prevalence of hyperglycaemia in singleton versus twin pregnancy. Diabetes Metab. Res. Rev. 31, 198–203 (2015).
Hedderson, M. et al. Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care 35, 1492–1498 (2012).
Anna, V., van der Ploeg, H. P., Cheung, N. W., Huxley, R. R. & Bauman, A. E. Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care 31, 2288–2293 (2008).
Zhang, C. & Ning, Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence. Am. J. Clin. Nutr. 94, 1975S–1979S (2011).
Bao, W. et al. Parental smoking during pregnancy and the risk of gestational diabetes in the daughter. Int. J. Epidemiol. 45, 160–169 (2016).
Tobias, D. K., Zhang, C., van Dam, R. M., Bowers, K. & Hu, F. B. Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 34, 223–229 (2011).
Zhang, C., Solomon, C. G., Manson, J. E. & Hu, F. B. A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. Arch. Intern. Med. 166, 543–548 (2006).
Zhang, C. et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLOS ONE 3, e3753 (2008).
Zhang, C. et al. Maternal plasma ascorbic acid (vitamin C) and risk of gestational diabetes mellitus. Epidemiology 15, 597–604 (2004).
Zhu, Y. et al. A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes. Am. J. Clin. Nutr. 107, 1017–1026 (2018).
Looman, M. et al. Pre-pregnancy dietary carbohydrate quantity and quality, and risk of developing gestational diabetes: the Australian longitudinal study on women’s health. Br. J. Nutr. 120, 435–444 (2018).
Chen, L., Hu, F. B., Yeung, E., Willett, W. & Zhang, C. Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus. Diabetes Care 32, 2236–2241 (2009).
Bao, W., Tobias, D. K., Hu, F. B., Chavarro, J. E. & Zhang, C. Pre-pregnancy potato consumption and risk of gestational diabetes mellitus: prospective cohort study. BMJ 352, h6898 (2016).
Bao, W., Tobias, D. K., Olsen, S. F. & Zhang, C. Pre-pregnancy fried food consumption and the risk of gestational diabetes mellitus: a prospective cohort study. Diabetologia 57, 2485–2491 (2014).
Bowers, K. et al. A prospective study of prepregnancy dietary iron intake and risk for gestational diabetes mellitus. Diabetes Care 34, 1557–1563 (2011).
Bowers, K., Tobias, D. K., Yeung, E., Hu, F. B. & Zhang, C. A prospective study of prepregnancy dietary fat intake and risk of gestational diabetes. Am. J. Clin. Nutr. 95, 446–453 (2012).
Bao, W., Bowers, K., Tobias, D. K., Hu, F. B. & Zhang, C. Prepregnancy dietary protein intake, major dietary protein sources, and the risk of gestational diabetes mellitus: a prospective cohort study. Diabetes Care 36, 2001–2008 (2013).
Bao, W. et al. Prepregnancy low-carbohydrate dietary pattern and risk of gestational diabetes mellitus: a prospective cohort study. Am. J. Clin. Nutr. 99, 1378–1384 (2014).
Zhang, C., Liu, S., Solomon, C. G. & Hu, F. B. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 29, 2223–2230 (2006).
Tobias, D. K. et al. Prepregnancy adherence to dietary patterns and lower risk of gestational diabetes mellitus. Am. J. Clin. Nutr. 96, 289–295 (2012).
Zhang, C. et al. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. BMJ 349, g5450 (2014).
Zalbahar, N., Najman, J., McIntyre, H. D. & Mamun, A. Parental pre-pregnancy obesity and the risk of offspring weight and body mass index change from childhood to adulthood. Clin. Obes. 7, 206–215 (2017).
Smarr, M. M. et al. Persistent organic pollutants and pregnancy complications. Sci. Total Environ. 551–552, 285–291 (2016).
Zhang, C. et al. A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes. Fertil. Steril. 103, 184–189 (2015).
Hinkle, S. N. et al. A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period. Diabetologia 59, 2594–2602 (2016).
Zhang, C. et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum. Reprod. Update 19, 376–390 (2013).
Kwak, S. H. et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61, 531–541 (2012).
Ren, J. et al. Genetic variation in MTNR1B is associated with gestational diabetes mellitus and contributes only to the absolute level of beta cell compensation in Mexican Americans. Diabetologia 57, 1391–1399 (2014).
Ding, M. et al. Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations. Diabetologia 61, 1758–1768 (2018).
Catalano, P. M., Tyzbir, E. D. & Sims, E. A. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13, 478–482 (1990).
Ellard, S., Bellanne-Chantelot, C. & Hattersley, A. T. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51, 546–553 (2008).
Hattersley, A. T. et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat. Genet. 19, 268–270 (1998). This landmark paper outlines the differing phenotypes encountered when maternal and fetal glucokinase genes are matched or mismatched.
Catalano, P. M. et al. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am. J. Obstet. Gynecol. 167, 913–919 (1992).
Catalano, P. M., Tyzbir, E. D., Roman, N. M., Amini, S. B. & Sims, E. A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am. J. Obstet. Gynecol. 165, 1667–1672 (1991).
Catalano, P. M., Huston, L., Amini, S. B. & Kalhan, S. C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am. J. Obstet. Gynecol. 180, 903–916 (1999). This paper provides detailed insight into the pathophysiology of GDM as compared with and contrasted to obesity without diabetes in a longitudinal cohort of women monitored over the course of pregnancy.
Buchanan, T. A. Pancreatic B cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J. Clin. Endocrinol. Metab. 86, 989–993 (2001).
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).
Friedman, J. E. et al. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48, 1807–1814 (1999).
McIntyre, Discovery H. D. knowledge, and action-diabetes in pregnancy across the translational spectrum: the 2016 Norbert Freinkel Award Lecture. Diabetes Care 41, 227–232 (2018).
Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665–668 (1996).
Kirwan, J. P. et al. Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J. Clin. Endocrinol. Metab. 89, 4678–4684 (2004).
Waters, T. P. et al. Does maternal insulin sensitivity improve immediately after delivery or do we need to wait unti six weeks postpartum? Am. J. Obstet. Gynecol. 212, S20 (2015).
Friedman, J. E., Kirwan, J. P., Jing, M., Presley, L. & Catalano, P. M. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes 57, 606–613 (2008).
Berggren, E. K., Presley, L., Amini, S. B., Hauguel-de Mouzon, S. & Catalano, P. M. Are the metabolic changes of pregnancy reversible in the first year postpartum? Diabetologia 58, 1561–1568 (2015).
Peters, R. K., Kjos, S. L., Xiang, A. & Buchanan, T. A. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347, 227–230 (1996).
Lewis, R. M. et al. The placental exposome: placental determinants of fetal adiposity and postnatal body composition. Ann. Nutr. Metab. 63, 208–215 (2013).
Desoye, G. & Shafrir, E. Placental metabolism and its regulation in health and diabetes. Mol. Aspects Med. 15, 505–682 (1994).
Hauguel, S., Desmaizieres, V. & Challier, J. C. Glucose uptake, utilization, and transfer by the human placenta as functions of maternal glucose concentration. Pediatr. Res. 20, 269–273 (1986).
Osmond, D. T., Nolan, C. J., King, R. G., Brennecke, S. P. & Gude, N. M. Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation. Diabetologia 43, 576–582 (2000).
Desoye, G. & Nolan, C. J. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy. Diabetologia 59, 1089–1094 (2016).
Haggarty, P., Page, K., Abramovich, D. R., Ashton, J. & Brown, D. Long-chain polyunsaturated fatty acid transport across the perfused human placenta. Placenta 18, 635–642 (1997).
Lewis, R. M., Wadsack, C. & Desoye, G. Placental fatty acid transfer. Curr. Opin. Clin. Nutr. Metab. Care 21, 78–82 (2018).
Dancis, J., Jansen, V., Kayden, H. J., Schneider, H. & Levitz, M. Transfer across perfused human placenta. II. Free fatty acids. Pediatr. Res. 7, 192–197 (1973).
Pagan, A. et al. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 305, E826–E833 (2013).
Prieto-Sanchez, M. T. et al. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Clin. Nutr. 36, 513–521 (2017).
Sen, D. K., Kaufmann, P. & Schweikhart, G. Classification of human placental villi. II. Morphometry. Cell Tissue Res. 200, 425–434 (1979).
Gauster, M., Desoye, G., Totsch, M. & Hiden, U. The placenta and gestational diabetes mellitus. Curr. Diab. Rep. 12, 16–23 (2012).
Cvitic, S., Desoye, G. & Hiden, U. Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus. Biomed. Res. Int. 2014, 145846 (2014).
Lassance, L. et al. Hyperinsulinemia stimulates angiogenesis of human fetoplacental endothelial cells: a possible role of insulin in placental hypervascularization in diabetes mellitus. J. Clin. Endocrinol. Metab. 98, E1438–E1447 (2013).
Loegl, J. et al. Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. Reproduction 152, 447–455 (2016).
Loegl, J. et al. Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy. Angiogenesis 19, 373–388 (2016).
Sun, Y. et al. Gestational diabetes mellitus modulates cholesterol homeostasis in human fetoplacental endothelium. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863, 968–979 (2018).
Scholler, M. et al. Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL. J. Clin. Endocrinol. Metab. 97, 2466–2474 (2012).
Desoye, G. The human placenta in diabetes and obesity: friend or foe? The 2017 Norbert Freinkel Award Lecture. Diabetes Care 41, 1362–1369 (2018). This article provides a comprehensive overview of placental structure and function in diabetic pregnancy.
Gauster, M. et al. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes 60, 2457–2464 (2011).
Cvitic, S. et al. The human placental sexome differs between trophoblast epithelium and villous vessel endothelium. PLOS ONE 8, e79233 (2013).
Knabl, J. et al. GDM alters expression of placental estrogen receptor alpha in a cell type and gender-specific manner. Reprod. Sci. 22, 1488–1495 (2015).
Sedlmeier, E. M. et al. Human placental transcriptome shows sexually dimorphic gene expression and responsiveness to maternal dietary n-3 long-chain polyunsaturated fatty acid intervention during pregnancy. BMC Genomics 15, 941 (2014).
Strutz, J. et al. Gestational diabetes alters microRNA signatures in human feto-placental endothelial cells depending on fetal sex. Clin. Sci. 132, 2437–2449 (2018).
Desoye, G. & Hauguel-de Mouzon, S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30 (Suppl. 2), S120–S126 (2007).
Watson, A. L., Skepper, J. N., Jauniaux, E. & Burton, G. J. Changes in concentration, localization and activity of catalase within the human placenta during early gestation. Placenta 19, 27–34 (1998).
Lappas, M. et al. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid. Redox Signal. 15, 3061–3100 (2011).
Hoch, D., Gauster, M., Hauguel-de Mouzon, S. & Desoye, G. Diabesity-associated oxidative and inflammatory stress signalling in the early human placenta. Mol. Aspects Med. 66, 21–30 (2018).
Desoye, G. & van Poppel, M. The feto-placental dialogue and diabesity. Best Pract. Res. Clin. Obstet. Gynaecol. 29, 15–23 (2015).
Eder, M. et al. Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates. Int. J. Obes. 40, 538–542 (2016).
Houshmand-Oeregaard, A. et al. DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy. PLOS ONE 12, e0187038 (2017).
Houshmand-Oeregaard, A. et al. Differential adipokine DNA methylation and gene expression in subcutaneous adipose tissue from adult offspring of women with diabetes in pregnancy. Clin. Epigenetics 9, 37 (2017).
Hjort, L. et al. Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children. JCI Insight 3, e122572 (2018).
Pettitt, D. J., Knowler, W. C., Baird, H. R. & Bennett, P. H. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 3, 458–464 (1980).
Beischer, N. A., Wein, P., Sheedy, M. T. & Steffen, B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust. N. Z. J. Obstet. Gynaecol. 36, 239–247 (1996).
Casey, B. M., Lucas, M. J., McIntire, D. D. & Leveno, K. J. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet. Gynecol. 90, 869–873 (1997).
Aberg, A., Rydhstrom, H., Kallen, B. & Kallen, K. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet. Gynecol. Scand. 76, 212–217 (1997).
Persson, B. & Hanson, U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 21(Suppl. 2), B79–B84 (1998).
Jensen, D. M. et al. Proposed diagnostic thresholds for gestational diabetes mellitus according to a 75-g oral glucose tolerance test. Maternal and perinatal outcomes in 3260 Danish women. Diabet Med. 20, 51–57 (2003).
Sermer, M. et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am. J. Obstet. Gynecol. 173, 146–156 (1995).
Sacks, D. A. et al. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am. J. Obstet. Gynecol. 172, 607–614 (1995).
Moses, R. G. & Calvert, D. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Is there a continuum of risk? Diabetes Care 18, 1527–1533 (1995).
Jensen, D. M. et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am. J. Obstet. Gynecol. 185, 413–419 (2001).
Jarrett, R. J. Gestational diabetes: a non-entity? BMJ 306, 37–38 (1993).
Metzger, B. E. et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008). This landmark epidemiological study defines, on a worldwide basis, the relationship between impaired glucose metabolism that is less severe than overt diabetes and pregnancy complications.
Crowther, C. A. et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352, 2477–2486 (2005). This landmark randomized controlled trial demonstrates that treatment of GDM is effective in reducing immediate pregnancy complications, including excess fetal growth and pregnancy-related hypertension.
Landon, M. B. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361, 1339–1348 (2009). This USA-based randomized controlled trial confirms that treatment of GDM reduces excess fetal growth, excess fetal adiposity and pregnancy-related hypertension.
Bellamy, L., Casas, J. P., Hingorani, A. D. & Williams, D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773–1779 (2009).
Cheung, N. W. & Byth, K. Population health significance of gestational diabetes. Diabetes Care 26, 2005–2009 (2003).
Lauenborg, J. et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27, 1194–1199 (2004).
Damm, P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int. J. Gynaecol. Obstet. 104 (Suppl. 1), S25–S26 (2009).
Damm, P., Kuhl, C., Bertelsen, A. & Molsted-Pedersen, L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am. J. Obstet. Gynecol. 167, 607–616 (1992).
Lowe, W. L. Jr. et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320, 1005–1016 (2018). This follow-up study from the landmark HAPO study demonstrates that GDM diagnosed using the IADPSG criteria is associated with long-term risk of T2DM in the mother and with risk of obesity in offspring (WHO 2013).
Lauenborg, J. et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J. Clin. Endocrinol. Metab. 90, 4004–4010 (2005).
Retnakaran, R. Hyperglycemia in pregnancy and its implications for a woman’s future risk of cardiovascular disease. Diabetes Res. Clin. Pract. 145, 193–199 (2018).
Retnakaran, R. & Shah, B. R. Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus. Diabetes Care 40, 101–108 (2017).
Kramer, C. K., Campbell, S. & Retnakaran, R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 62, 905–914 (2019).
Harder, T. et al. Pancreatic islet transplantation in diabetic pregnant rats prevents acquired malformation of the ventromedial hypothalamic nucleus in their offspring. Neurosci. Lett. 299, 85–88 (2001).
Aerts, L. & Van Assche, F. A. Animal evidence for the transgenerational development of diabetes mellitus. Int. J. Biochem. Cell Biol. 38, 894–903 (2006).
Silverman, B. L. et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 (Suppl. 2), 121–125 (1991).
Dabelea, D. et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49, 2208–2211 (2000).
Fraser, A. & Lawlor, D. A. Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr. Diab. Rep. 14, 489 (2014).
Kelstrup, L. et al. Insulin resistance and impaired pancreatic beta-cell function in adult offspring of women with diabetes in pregnancy. J. Clin. Endocrinol. Metab. 98, 3793–3801 (2013).
Grunnet, L. G. et al. Adiposity, dysmetabolic traits, and earlier onset of female puberty in adolescent offspring of women with gestational diabetes mellitus: a clinical study within the Danish National Birth Cohort. Diabetes Care 40, 1746–1755 (2017).
Lowe, W. L. Jr. et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes and childhood glucose metabolism. Diabetes Care 42, 372–380 (2019).
Lowe, W. L. Jr. et al. Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study. Diabetologia 62, 598–610 (2019).
Clausen, T. D. et al. Cognitive function in adult offspring of women with gestational diabetes—the role of glucose and other factors. PLOS ONE 8, e67107 (2013).
Xiang, A. H. et al. Association of maternal diabetes with autism in offspring. Jama 313, 1425–1434 (2015).
Xiang, A. H. et al. Maternal gestational diabetes mellitus, type 1 diabetes, and type 2 diabetes during pregnancy and risk of ADHD in offspring. Diabetes Care 41, 2502–2508 (2018).
Gillman, M. W. et al. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care 33, 964–968 (2010).
Landon, M. B. et al. Mild gestational diabetes mellitus and long-term child health. Diabetes Care 38, 445–452 (2015).
Luoto, R. et al. Primary prevention of gestational diabetes mellitus and large-for-gestational-age newborns by lifestyle counseling: a cluster-randomized controlled trial. PLOS Med. 8, e1001036 (2011).
Dodd, J. M. et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ 348, g1285 (2014).
Zhang, C., Rawal, S. & Chong, Y. S. Risk factors for gestational diabetes: is prevention possible? Diabetologia 59, 1385–1390 (2016).
Song, C. et al. Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obes. Rev. 19, 421–429 (2018).
Russo, L. M., Nobles, C., Ertel, K. A., Chasan-Taber, L. & Whitcomb, B. W. Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet. Gynecol. 125, 576–582 (2015).
Sanabria-Martinez, G. et al. Effectiveness of physical activity interventions on preventing gestational diabetes mellitus and excessive maternal weight gain: a meta-analysis. BJOG 122, 1167–1174 (2015).
Song, C., Li, J., Leng, J., Ma, R. C. & Yang, X. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes. Rev. 17, 960–969 (2016).
Han, S., Crowther, C. A., Middleton, P. & Heatley, E. Different types of dietary advice for women with gestational diabetes mellitus. Cochrane Database Syst. Rev. 3, CD009275 (2013).
Bain, E. et al. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst. Rev. 4, CD010443 (2015).
Celentano, C. et al. Myo-Inositol supplementation to prevent gestational diabetes mellitus. Curr. Diab Rep. 16, 30 (2016).
Santamaria, A. et al. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J. Matern. Fetal Neonatal Med. 29, 3234–3237 (2016).
Farren, M. et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care 40, 759–763 (2017).
Crawford, T. J., Crowther, C. A., Alsweiler, J. & Brown, J. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database Syst. Rev. 12, CD011507 (2015).
Luoto, R., Laitinen, K., Nermes, M. & Isolauri, E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br. J. Nutr. 103, 1792–1799 (2010).
Callaway, L. K. et al. Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial. Diabetes Care 42, 364–371 (2019).
Lindsay, K. L. et al. Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (probiotics in pregnancy study). Am. J. Clin. Nutr. 99, 1432–1439 (2014).
Lindsay, K. L., Walsh, C. A., Brennan, L. & McAuliffe, F. M. Probiotics in pregnancy and maternal outcomes: a systematic review. J. Matern. Fetal Neonatal Med. 26, 772–778 (2013).
Pellonpera, O. et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled, double-blind clinical trial. Diabetes Care 42, 1009–1017 (2019).
Jarde, A. et al. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy Childbirth 18, 14 (2018).
Zheng, J., Feng, Q., Zheng, S. & Xiao, X. The effects of probiotics supplementation on metabolic health in pregnant women: an evidence based meta-analysis. PLOS ONE 13, e0197771 (2018).
Barrett, H. L., Dekker Nitert, M., Conwell, L. S. & Callaway, L. K. Probiotics for preventing gestational diabetes. Cochrane Database Syst. Rev. 2, CD009951 (2014).
Chiswick, C. et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 3, 778–786 (2015).
Dodd, J. M. et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 15–24 (2019).
Glueck, C. J., Pranikoff, J., Aregawi, D. & Wang, P. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil. Steril. 89, 625–634 (2008).
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E. & Balen, A. H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 5, CD003053 (2012).
Carpenter, M. W. & Coustan, D. R. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144, 768–773 (1982).
Berggren, E. K., Boggess, K. A., Stuebe, A. M. & Jonsson Funk, M. National Diabetes Data Group versus Carpenter-Coustan criteria to diagnose gestational diabetes. Am. J. Obstet. Gynecol. 205, 253.e1–253.e7 (2011).
ACOG Committee on Practice Bulletins. Practice Bulletin No. 137: gestational diabetes mellitus. Obstet. Gynecol. 122, 406–416 (2013).
Metzger, B. E. et al. The hyperglycemia and adverse pregnancy outcome (HAPO) Study. Int. J. Gynaecol. Obstet. 78, 69–77 (2002).
Metzger, B. E. et al. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 126, e1545–e1552 (2010).
Sacks, D. A. et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the hyperglycemia and adverse pregnancy outcome (HAPO) study. Diabetes Care. 35, 526–528 (2012).
Diabetes, I. Ao. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010).
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 42, S13–S28 (2019).
Blumer, I. et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98, 4227–4249 (2013).
Nankervis, A., McIntyre, H. D., Moses, R. G., Ross, G. P. & Callaway, L. K. Testing for gestational diabetes mellitus in Australia. Diabetes Care 36, e64 (2013).
Ikenoue, S. et al. Clinical impact of women with gestational diabetes mellitus by the new consensus criteria: two year experience in a single institution in Japan. Endocr. J. 61, 353–358 (2014).
Kautzky-Willer, A. et al. Gestational diabetes mellitus [German]. Wien. Klin. Wochenschr. 124 (Suppl. 2), 58–65 (2012).
Hod, M. et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int. J. Gynaecol. Obstet. 131, S173–S211 (2015).
Diehl, K. et al. German gynecologists’ experience with a universal screening for gestational diabetes mellitus in daily practice: a qualitative study. J. Turk. Ger. Gynecol. Assoc. 17, 10–15 (2016).
Rowan, J. et al. New Zealand National GDM Guidelines: an alternative view of some good practice points. Aust. N. Z. J. Obstet. Gynaecol. 55, 17–20 (2015).
Benhalima, K. et al. A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58, 1422–1429 (2015).
Sadikot, S., Purandare, C. N., Cho, N. H. & Hod, M. FIGO-IDF joint statement and declaration on hyperglycemia in pregnancy. Diabetes Res. Clin. Pract. 145, 1–4 (2018).
Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet. Gynecol. 131, e49–e64 (2018).
Feig, D. S. et al. Diabetes and pregnancy. Can. J. Diabetes 42 (Suppl. 1), 255–282 (2018).
National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period (NICE, 2015).
van Leeuwen, M. et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG 119, 393–401 (2012).
Saccone, G., Khalifeh, A., Al-Kouatly, H. B., Sendek, K. & Berghella, V. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J. Matern. Fetal Neonatal Med. https://doi.org/10.1080/14767058.2018.1519543 (2018).
Sievenpiper, J. L., McDonald, S. D., Grey, V. & Don-Wauchope, A. C. Missed follow-up opportunities using a two-step screening approach for gestational diabetes. Diabetes Res. Clin. Pract. 96, e43–e46 (2012).
Donovan, L. E., Savu, A., Edwards, A. L., Johnson, J. A. & Kaul, P. Prevalence and timing of screening and diagnostic testing for gestational diabetes mellitus: a population-based study in Alberta, Canada. Diabetes Care 39, 55–60 (2016).
McIntyre, H. D. Diagnosing gestational diabetes mellitus: rationed or rationally related to risk? Diabetes Care 36, 2879–2880 (2013).
McIntyre, H. D. et al. Gestational diabetes mellitus: does one size fit all? A challenge to uniform worldwide diagnostic thresholds. Diabetes Care 41, 1339–1342 (2018).
American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes — 2019. Diabetes Care 42, S165–S172 (2019).
Gunderson, E. P. Gestational diabetes and nutritional recommendations. Curr. Diab. Rep. 4, 377–386 (2004).
Viana, L. V., Gross, J. L. & Azevedo, M. J. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care 37, 3345–3355 (2014).
Rasmussen, K. M., Catalano, P. M. & Yaktine, A. L. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr. Opin. Obstet. Gynecol. 21, 521–526 (2009).
Rizzo, T., Metzger, B. E., Burns, W. J. & Burns, K. Correlations between antepartum maternal metabolism and intelligence of offspring. N. Engl. J. Med. 325, 911–916 (1991).
American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes — 2018. Diabetes Care 41, S137–S143 (2018).
Ruchat, S. M. et al. Effectiveness of exercise interventions in the prevention of excessive gestational weight gain and postpartum weight retention: a systematic review and meta-analysis. Br. J. Sports Med. 52, 1347–1356 (2018).
Vaarasmaki, M. Is it worth treating gestational diabetes: if so, when and how? Diabetologia 59, 1391–1395 (2016).
Kurtzhals, L. L. et al. The impact of restricted gestational weight gain by dietary intervention on fetal growth in women with gestational diabetes mellitus. Diabetologia 61, 2528–2538 (2018).
Kjos, S. L. & Schaefer-Graf, U. M. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 30 (Suppl. 2), 200–205 (2007).
Charlton, R. A. et al. Prescribing of antidiabetic medicines before, during and after pregnancy: a study in seven European regions. PLOS ONE 11, e0155737 (2016).
Lepercq, J. et al. Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy. Obstet. Gynecol. Int. 2012, 649070 (2012).
Mikkelsen, M. R., Nielsen, S. B., Stage, E., Mathiesen, E. R. & Damm, P. High maternal HbA1c is associated with overweight in neonates. Dan. Med. Bull. 58, A4309 (2011).
Herrera, K. M. et al. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. Am. J. Obstet. Gynecol. 213, 426.e1–426.e7 (2015).
Jia, Y., Lao, Y., Zhu, H., Li, N. & Leung, S. W. Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials. Obes. Rev. 20, 1–12 (2019).
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R. & Moore, M. P. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358, 2003–2015 (2008).
Ijas, H. et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118, 880–885 (2011).
Balsells, M. et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350, h102 (2015).
Barbour, L. A. & Feig, D. S. Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach. Diabetes Care 42, 396–399 (2019).
Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34, 2279–2284 (2011).
Battin, M. R. et al. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial. BMC Pediatr. 15, 54 (2015).
Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res. Care 6, e000456 (2018).
Ijas, H., Vaarasmaki, M., Saarela, T., Keravuo, R. & Raudaskoski, T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG 122, 994–1000 (2015).
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M. & Gonzales, O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343, 1134–1138 (2000).
Schwartz, R. A., Rosenn, B., Aleksa, K. & Koren, G. Glyburide transport across the human placenta. Obstet. Gynecol. 125, 583–588 (2015).
Hebert, M. F. et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin. Pharmacol. Ther. 85, 607–614 (2009).
Camelo Castillo, W. et al. Association of adverse pregnancy outcomes with glyburide versus insulin in women with gestational diabetes. JAMA Pediatr. 169, 452–458 (2015).
Tobias, D. K. et al. Healthful dietary patterns and type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus. Arch. Intern. Med. 172, 1566–1572 (2012).
Bao, W. et al. Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study. JAMA Intern. Med. 174, 1047–1055 (2014).
Bao, W. et al. Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study. Diabetologia 58, 1212–1219 (2015).
Gunderson, E. P. et al. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study. Ann. Intern. Med. 163, 889–898 (2015).
Buchanan, T. A. et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51, 2796–2803 (2002).
Aroda, V. R. et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J. Clin. Endocrinol. Metab. 100, 1646–1653 (2015).
Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program outcomes study. Diabetes Care 42, 601–608 (2019).
Wilkinson, S. A., McCray, S., Beckmann, M., Parry, A. & McIntyre, H. D. Barriers and enablers to translating gestational diabetes guidelines into practice. Pract. Diabetes 31, 67–72a (2014).
Dalfra, M. G., Nicolucci, A., Bisson, T., Bonsembiante, B. & Lapolla, A. Quality of life in pregnancy and post-partum: a study in diabetic patients. Qual. Life Res. 21, 291–298 (2012).
Danyliv, A. et al. Health related quality of life two to five years after gestational diabetes mellitus: cross-sectional comparative study in the ATLANTIC DIP cohort. BMC Pregnancy Childbirth 15, 274 (2015).
Marchetti, D., Carrozzino, D., Fraticelli, F., Fulcheri, M. & Vitacolonna, E. Quality of life in women with gestational diabetes mellitus: a systematic review. J. Diabetes Res. 2017, 7058082 (2017).
Pace, R., Rahme, E., Da Costa, D. & Dasgupta, K. Association between gestational diabetes mellitus and depression in parents: a retrospective cohort study. Clin. Epidemiol. 10, 1827–1838 (2018).
Clark, C. E., Rasgon, N. L., Reed, D. E. 2nd & Robakis, T. K. Depression precedes, but does not follow, gestational diabetes. Acta Psychiatr. Scand. 139, 311–321 (2019).
Egan, A. M. et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia 60, (1913–1921 (2017).
Goveia, P. et al. Lifestyle intervention for the prevention of diabetes in women with previous gestational diabetes mellitus: a systematic review and meta-analysis. Front. Endocrinol. 9, 583 (2018).
Kim, C. Maternal outcomes and follow-up after gestational diabetes mellitus. Diabet. Med. 31, 292–301 (2014).
Wexler, D. J. et al. Research gaps in gestational diabetes mellitus: executive summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Obstet. Gynecol. 132, 496–505 (2018). This paper provides a summary of the areas requiring further research in GDM, which provides an outline of current evidence gaps and a blueprint for future research priorities.
Poon, L. C., McIntyre, H. D., Hyett, J. A., da Fonseca, E. B. & Hod, M. The first-trimester of pregnancy – a window of opportunity for prediction and prevention of pregnancy complications and future life. Diabetes Res. Clin. Pract. 145, 20–30 (2018).
Ghosh, P. et al. Plasma glycated CD59, a novel biomarker for detection of pregnancy-induced glucose intolerance. Diabetes Care 40, 981–984 (2017).
Bahado-Singh, R. O. et al. Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus. Am. J. Obstet. Gynecol. 206, 422.e1–422.e5 (2012).
van Poppel, M. N., Eder, M., Lang, U. & Desoye, G. Sex-specific associations of insulin-like peptides in cord blood with size at birth. Clin. Endocrinol. 89, 187–193 (2018).
Guzman-Gutierrez, E. et al. Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in gestational diabetes mellitus. Microcirculation 21, 26–37 (2014).
Li, J. et al. The impact of umbilical blood flow regulation on fetal development differs in diabetic and non-diabetic pregnancy. Kidney Blood Press. Res. 39, 369–377 (2014).
Catalano, P. & deMouzon, S. H. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int. J. Obes. 39, 642–649 (2015).
Finneran, M. M. & Landon, M. B. Oral agents for the treatment of gestational diabetes. Curr. Diab. Rep. 18, 119 (2018).
Hanem, L. G. E. et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5–10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc. Health 3, 166–174 (2019).
Hanem, L. G. E. et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J. Clin. Endocrinol. Metab. 103, 1612–1621 (2018).
Hod, M., Kapur, A. & McIntyre, H. D. Evidence in support of the international association of diabetes in pregnancy study groups’ criteria for diagnosing gestational diabetes worldwide in 2019. Am. J. Obstet. Gynecol. https://doi.org/10.1016/j.ajog.2019.01.206 (2019).
Acknowledgements
C.Z. is supported by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH.
Author information
Authors and Affiliations
Contributions
Introduction (H.D.M.); Epidemiology (C.Z.); Mechanisms/pathophysiology (P.C. and G.D.); Diagnosis, screening and prevention (H.D.M., C.Z. and E.R.M.); Management (P.C. and E.R.M.); Quality of life (P.D.); Outlook (H.D.M., P.C., C.Z., G.D. and P.D.); Overview of the Primer (H.D.M.).
Corresponding author
Ethics declarations
Competing interests
P.D. is participating in multi-centre and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. E.R.M. is participating in multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk. E.R.M. has given talks for Novo Nordisk, AstraZeneca, Lilly and Sanofi Aventis and has received a salary for these tasks. H.D.M., C.Z., P.C. and G.D. declare no competing interests.
Additional information
Peer review information
Nature Reviews Disease Primers thanks D. Coustan, T. Buchanan and L. Sobrevia for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related Links
Rights and permissions
About this article
Cite this article
McIntyre, H.D., Catalano, P., Zhang, C. et al. Gestational diabetes mellitus. Nat Rev Dis Primers 5, 47 (2019). https://doi.org/10.1038/s41572-019-0098-8
Accepted:
Published:
DOI: https://doi.org/10.1038/s41572-019-0098-8
This article is cited by
-
Cross-cultural adaptation and validation to Brazilian Portuguese of the ‘knowledge of gestational diabetes (GDM)’ questionnaire for women with GDM
Diabetology & Metabolic Syndrome (2024)
-
Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study
BMC Endocrine Disorders (2024)
-
Effect of arsenic on the risk of gestational diabetes mellitus: a systematic review and meta-analysis
BMC Public Health (2024)
-
Association of free fatty acid in first trimester with the risk of gestational diabetes mellitus: a nested case-control study
BMC Endocrine Disorders (2024)
-
A holistic lifestyle mobile health intervention for the prevention of type 2 diabetes and common mental disorders in Asian women with a history of gestational diabetes: a randomised control trial with 3-year follow-up protocol
Trials (2024)